NARILIS was jointly created by the University of Namur and the CHU UCL Namur. NARILIS promotes multidisciplinary life sciences research with the aim to further improve health and wellbeing in human and animals. NARILIS supports research expanding our understanding of fundamental biological processes underlying normal and pathological conditions, as well...
Read More
MyCellHub is a spin-off of the KU Leuven, founded in 2019 and raised over €1M with a broad investors consortium. The team has extensive knowledge in both cell therapy manufacturing and software development for highly regulated industries. MyCellHub is part of the Horizon 2020 Eurostars project and has been sponsored...
Read More
Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming Women’s Health by offering new choices through innovation, with a focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. Its three lead development candidates...
Read More
Minoryx Therapeutics is a private VC-backed company developing innovative therapies for the treatment of orphan CNS (central nervous system) diseases. Leriglitazone was evaluated in a double-blind, placebo-controlled phase 2/3 clinical study (ADVANCE) in adult AMN patients in EU and US, overall showing a significant effect on reducing progression of cerebral...
Read More
Lambda-X creates and manufactures optical systems for metrology and imaging applications. Moving fast from an optical principle to a high-tech product is how we help you to innovate. Anywhere a Commercial-Off-The-Shelf (COTS) metrology tool doesn’t exist, Lambda-X offers a path with custom optical systems. Numerous applications in a number of...
Read More
A software solution design and development company, specializing in the management of oncology treatments and other complex treatments in hospitals. Website
Read More
KitoZyme is a “green biotech company” created in 2000, starting from academic research on fungal-derived biopolymers at the University of Liege. From a technological start-up, KitoZyme has gradually evolved into an industrial and commercial company, employing 30 people and selling its products in more than 40 countries. KitoZyme is the...
Read More
KiOmed Pharma offers animal-free, ultrapure chitosan-based breakthrough biomaterials for the development of safer and highly efficient therapeutic medical devices and implants for joint health, ophthalmology, tissue engineering and biosurgery. Website
Read More